Back to results
US 9,850,320 B2Granted
Heterodimeric antibodies to CD3 X CD20
AssigneeXencor, Inc.
InventorsMatthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal, Sung-Hyung Lee
Life of this patent
Estimating the term…
Abstract
The present invention is directed to novel heterodimeric antibodies.
Claims5
A heterodimeric antibody comprising:
- a) a first monomer comprising SEQ ID NO:323;
- b) a second monomer comprising SEQ ID NO:324;
- and
- c) a light chain comprising SEQ ID NO:325.
1 more element
A nucleic acid composition comprising:
- a) a first nucleic acid sequence encoding SEQ ID NO:323;
- b) a second nucleic acid sequence encoding SEQ ID NO:324;
- and
- c) a third nucleic acid sequence encoding SEQ ID NO:325.
1 more element
An expression vector composition comprising:
- a) a first expression vector comprising a first nucleic acid sequence encoding SEQ ID NO:323;
- b) a second expression vector comprising a second nucleic acid sequence encoding SEQ ID NO:324;
- and
- c) a third expression vector comprising a third nucleic acid sequence encoding SEQ ID NO:325.
1 more element
Dependencies are inferred from the claim text.